Journal of Clinical Epidemiology
Volume 50, Issue 7 , Pages 857-863 , July 1997

Potential Adverse Outcomes of Psychotropic and Narcotic Drug Use in Canadian Seniors

  • Erika M Ebly

      Affiliations

    • Departments of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada T2N 4N1
    • ,
  • David B Hogan

      Affiliations

    • Departments of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada T2N 4N1
    • Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1
    • Corresponding Author InformationDavid B. Hogan, M.D., Health Sciences Centre, 3330 Hospital Drive NW, Calgary, Alberta, Canada T2N 4N1
    • ,
  • Tak S Fung

      Affiliations

    • University Computing Services, University of Calgary, Calgary, Alberta, Canada T2N 4N1

,Accepted 23 October 1996.

References 

  1. Hobson M. Medications in older patients. West J Med. 1992;157:539–543
  2. Skoog T, Nilsson L, Landahl S, et al.  Mental disorders and the use of psychotrophic drugs in an 85-year-old urban population. Int Psychogeriatrics. 1993;5:33–48
  3. Tamblyn RM, McLeod PJ, Abrahamowicz M, et al.  Questionable prescribing for elderly patients in Quebec. Can Med Assoc J. 1994;150:1801–1809
  4. Ray WA, Federspiel CF, Schaffner W. A study of antipsychotic drug use in nursing homes (epidemiological evidence suggesting misuse). Am J Public Health. 1980;70:485–491
  5. Williams B, Single E, Mackenzie D. In: Licit and illicit drugs. Canadian Profile: Alcohol, Tobacco & Other Drugs. Ottawa: Canadian Centre on Substance Abuse, 1995; 4: 115–204.
  6. Shorr RI, Griffin MR, Daugherty JR, et al.  Opioid analgesics and the risk of hip fracture in the elderly (codeine and propoxyphen). J Gerontology. 1992;47(4):M111–M115
  7. SPC staff . Handbook of psychotrophic drugs. Springhouse, PA: Springhouse Corporation; 1991;
  8. Tune LE, Bylsma FW. Benzodiazepine-induced and anticholinergic-induced delirium in the elderly. Int Psychogeriatrics. 1991;3(2):397–408
  9. Salzman C. Antidepressants. Clin Geriatr Med. 1990;6(2):399–410
  10. Wilcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA. 1994;272:292–296
  11. Beers MH, Ouslander JG, Fingold SF, et al.  Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med. 1992;117:684–689
  12. Beers MH, Ouslander JG, Rollingher I, et al.  Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825–1832
  13. Stuck AE, Beers MH, Steiner A, et al.  Inappropriate medication use in community-residing older persons. Arch Intern Med. 1994;154:2195–2200
  14. Baker SP, Harvey AH. Fall injury in the elderly. Clin Geriatr Med. 1985;1(3):501–512
  15. Cumming RG, Miller JP, Kelsey JL, et al.  Medications and multiple falls in elderly people (the St. Louis OASIS study). Age Ageing. 1991;20(6):455–461
  16. Serock GS, Shimkin EE. Benzodiazepine sedatives and the risk of falling in a community-dwelling elderly cohort. Arch Intern Med. 1988;148:2441–2444
  17. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988;319:1701–1707
  18. Blake AJ, Morgan K, Bendall MJ, et al.  Falls by elderly people at home (prevalence and associated factors). Age Ageing. 1988;17:365–372
  19. Trewin VF, Lawrence CJ, Veitch GB. An investigation of the association of benzodiazepines and other hypnotics with the incidence of falls in the elderly. J Clin Pharm. 1992;17(2):129–133
  20. Herings RMC, Stricker BHC, deBoer A, et al.  Benzodiazepines and the risk of falling leading to femur fractures. Arch Intern Med. 1995;155:1801–1807
  21. Ruthazer R, Lipsitz LA. Antidepressants and falls among elderly people in long-term care. Am J Public Health. 1993;83(5):746–749
  22. Lipsitz LA, Jonsson PV, Kelley MM, et al.  Causes and correlates of recurrent falls in ambulatory frail elderly. J Gerontology. 1991;46(4):M114–M122
  23. Wickham C, Cooper C, Margetts BM, et al.  Muscle strength, activity, housing and the risk of falls in elderly people. Age Ageing. 1989;18:47–51
  24. Prudham D, Grimley Evans J. Factors associated with falls in the elderly (a community study). Age Ageing. 1981;10:141–146
  25. Yip YB, Cumming RG. The association between medications and falls in Australian nursing-home residents. Med J Aust. 1994;160:14–18
  26. Lilley JM, Arie T, Chilvers CED. Accidents involving older people. Age Ageing. 1995;24:346–365
  27. Larson EB, Kukull WA, Buchner D, et al.  Adverse drug reactions associated with global cognitive impairment in elderly persons. Arch Intern Med. 1987;107:169–173
  28. Golombok S, Moodley P, Lader M. Cognitive impairment in long-term benzodiazepine users. Psychol Med. 1988;18:365–374
  29. Bowen JD, Larson EB. Drug-induced cognitive impairment. Drugs Aging. 1993;3(4):349–357
  30. Schor JD, Levkoff SU, Lipsitz LA, et al.  Risk factors for delirium in hospitalized elderly. JAMA. 1992;267(6):827–831
  31. Ensrud K, Nevitt MC, Yunis C, et al.  Correlates of impaired function in older women. J Am Geriatr Soc. 1994;42:481–489
  32. Canadian Study of Health and Aging Working Group . Canadian Study of Health and Aging (study methods and prevalence of dementia). Can Med Assoc J. 1994;150:899–913
  33. Teng EL, Chui HC. The modified mini-mental state (3MS) examination. J Clin Psychiatry. 1987;48:314–318
  34. Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly (results from the Canadian Study of Health and Aging). Arch Neurol. 1995;52:612–619
  35. American Psychiatric Association . Diagnostic and statistics manual of mental disorders (DSMIII-R). Washington, DC: American Psychiatric Association; 1987;
  36. Cummings SR, Nevitt MC, Kidd S. Forgetting falls (the limited accuracy of recall of falls in the elderly). J Am Geriatr Soc. 1996;36:613–616
  37. Mattila MJ, Saarialho-Kere U, Mattila M. Acute effects of sertraline, amitriptyline, and placebo on the psychomotor performance of healthy subjects over 50 years of age. J Clin Psychiatry. 1988;49(8 Suppl):52–58
  38. Kramer M, Schoen LS. Problems in the use of long-acting hypnotics in older patients. J Clin Psychiatry. 1984;45:176–177
  39. Neutel CI, Hirdes JP, Maxwell CJ, et al.  New evidence on benzodiazepine use and falls. Age Ageing. 1996;25:273–278
  40. Shorr RI, Bauwens SF. Diagnosis and treatment of outpatient insomnia by psychiatric and nonpsychiatric physicians. Am J Med. 1992;93:78–82
  41. Barnas C, Whitworth AB, Fleischacken WW. Are patterns of benzodiazepine use predictable?. Psychopharmacology. 1993;111:301–305
  42. Garrard J, Makris L, Dunham T, et al.  Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations. JAMA. 1991;265:463–467
  43. Ferrell BA. Pain management in elderly people. J Am Geriatr Soc. 1991;39:64–73
  44. Ferrell BA. Pain evaluation and management in the nursing home. Ann Intern Med. 1995;123:681–687
  45. Foster A, Young J. Incidence and consequences of falls due to stroke. Br Med J. 1995;311:83–866997
  46. Nevitt MC, Cummings SR, Kidd S, et al.  Risk factors for recurrent nonsyncopal falls. JAMA. 1989;261:2663–2668
  47. Lord SR, Ward JA, Williams P, et al.  Physiological factors associated with falls in older community-dwelling women. J Am Geriatr Soc. 1994;42:1110–1117
  48. Jones D. Characteristics of elderly people taking psychotropic medications. Drugs Aging. 1992;2(5):389–394
  49. Foy A, O'Connell D, Henry D, et al.  Benzodiazepine use as a cause of cognitive impairment in elderly hospital inpatients. J Gerontology. 1995;50A(2):M99–M106
  50. Lamy PP. Adverse drug effects. Clin Geriatr Med. 1990;6:293–307
  51. Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging. 1993;3(4):335–348
  52. Morris JC, Rubin EH, Morris EJ, et al.  Disease is an important risk factor for falls in itself. J Gerontology. 1987;42:412–417
  53. Salzman C, Fisher J, Nobel K, et al.  Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. International Journal of Geriatric Psychiatry. 1992;7:89–93
  54. Bruera E, Macmillan K, Hanson J, et al.  The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain. 1989;39:13–16
  55. Campbell AJ. Drug treatment as a cause of falls in old age. A review of the offending agents. Drugs Aging. 1991;1(4):289–302
  56. Robin DW, Hasan SS, Lichtenstein MJ, et al.  Dose-related effect of triazolam on postural sway. Clin Pharmacol Ther. 1991;49(5):581–588

PII: S0895-4356(97)00118-2

Journal of Clinical Epidemiology
Volume 50, Issue 7 , Pages 857-863 , July 1997

Article Tools

* Image Usage & Resolution